Target intelligence / Profile preview

Immunoglobulin heavy variable region pseudogene (IGHV pseudogene)

Target
IGHV pseudogene
Molecular classification
Pseudogene, Immunoglobulin gene family, Immunoglobulin heavy chain variable region pseudogene
01

Overview

Immunoglobulin heavy chain variable region (IGHV) pseudogenes are segments of DNA located within the immunoglobulin heavy chain locus (14q32.33) that resemble functional IGHV genes but carry mutations or deletions that prevent them from encoding a functional immunoglobulin heavy chain variable domain. These pseudogenes are considered evolutionary remnants and do not produce protein products. They may appear in next-generation sequencing studies or immunogenomic analyses, but they do not contribute to the immune repertoire or serve as therapeutic targets. The designation "novel IGHV pseudogene" likely refers to a newly annotated or previously uncharacterized pseudogene in this locus, rather than a distinct biological entity with function or therapeutic relevance. The IMGT database catalogues several human IGHV pseudogenes, all explicitly labeled as pseudogenes with the status "P" for functionality (non-functional), located at chromosomal region 14q32.33. These pseudogenes may create annotation challenges in immunoinformatics but are not included in functional gene sets for therapeutic targeting or biomarker development. Use of ENSG00000271691 as a "therapeutic target" or "receptor" is not scientifically accurate; for structured applications, this entry should be flagged as a pseudogene and not a valid target. ENSG00000271691 ("novel IGHV pseudogene") should be treated as a pseudogene related to the immunoglobulin family, not as a functional molecule or therapeutic target; most fields (including drugs, function, disease roles) are not applicable.

Other names
IGHV pseudogeneimmunoglobulin heavy chain variable region pseudogenepossible alternative clone designations (no unique, common alias for "novel" pseudogenes)
02

Mechanism of action

None (pseudogenes are not targeted therapeutically)

03

Biological functions

None (pseudogenes are not transcribed into functional proteins and lack direct biological function)
04

Disease associations

Other (no direct disease roles; possible rare involvement in immunoglobulin gene rearrangement errors, but not established)
05

Safety considerations

None (no direct safety or therapeutic implications)
06

Interacting drugs

None (pseudogenes are not known to interact with drugs)
07

Biomarkers

None established

Beyond the preview

Go deeper on Immunoglobulin heavy variable region pseudogene (IGHV pseudogene).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable region pseudogene (IGHV pseudogene).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call